Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Tools and Technologies for Improving Outcomes for Maternal Health (Discontinued)

Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health (NOT-EB-23-005) is sponsored by National Institutes of Health (NIH). This Notice of Special Interest (NOSI) supports small business initiatives focused on innovative tools and technologies to improve outcomes for maternal health.

Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001) is sponsored by National Institutes of Health (NIH). This NOSI encourages Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) applications to develop technologies or tools to quantitatively predict or indicate an increased risk for maternal morbidity and mortality (MMM).

Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health, NOT-EB-23-005 is sponsored by National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This Notice of Special Interest (NOSI) seeks to advance maternal health research through small business innovation, focusing on projects for detecting, predicting, and/or monitoring conditions or disorders during pregnancy and/or the post-partum period that contribute to maternal morbidity and mortality. This includes clinical trials. The initiative is part of the 'Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)' initiative. Small businesses are encouraged to develop technologies, remote monitoring systems, clinical analytics platforms, and healthcare delivery solutions. While not explicitly mentioning GIS, the focus on 'clinical analytics platforms' and 'maternal risk prediction' suggests that GIS secondary data analysis could be a relevant tool in developing such innovative solutions.

Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001) is sponsored by National Institutes of Health (NIH). This funding opportunity invites Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) applications to develop technologies or tools to quantitatively predict or indicate an increased risk for maternal morbidity and mortality. It is part of the IMPROVE initiative, supporting research to reduce preventable maternal deaths and improve women's health during and after pregnancy.

Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations is sponsored by National Institute of Mental Health (NIMH) / NIH. This NOSI encourages Small Business Concerns (SBCs) to submit SBIR and STTR grant applications for developing, refining, and evaluating digital mental health technologies. This includes mobile health (mHealth) and health information technology.

Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations (NOT-MH-24-120) is sponsored by National Institute of Mental Health (NIMH) / NIH. This NOSI encourages Small Business Concerns (SBCs) to submit SBIR and STTR grant applications that propose to develop, refine, and evaluate digital mental health technologies.

Notice of Special Interest (NOSI): SBIR/STTR High-Priority Areas for Digital Mental Health Innovations (NOT-MH-24-120) is sponsored by National Institute of Mental Health (NIMH), NIH. This NOSI encourages Small Business Concerns (SBCs) to submit SBIR and STTR grant applications for developing, refining, and evaluating digital mental health technologies. This includes mobile health (mHealth) using wearable sensors and health information technology that collects or uses biological, social, and behavioral data. Research on technologies that help understand the trajectory and etiology of mental disorders, predict and prevent mental illness, and support mental health research and clinical trial design is encouraged. This aligns well with electrodermal activity stress sensors for illness detection.